Skip to main content
. 2022 Oct 3;5(6):e874. doi: 10.1002/hsr2.874

Figure 3.

Figure 3

Forest plot for the seroconversion rate after the second dose of mRNA‐based vaccines, (A) Cases, (B) Controls